What Is FSH in a Blood Test? Levels Explained

FSH, or follicle-stimulating hormone, is a hormone produced by the pituitary gland that plays a central role in reproduction. When your doctor orders an FSH blood test, they are measuring how much of this hormone is circulating in your bloodstream to get a snapshot of how your reproductive system is functioning. The results can help diagnose fertility problems, confirm menopause, identify pituitary disorders, and evaluate unexplained changes in menstrual cycles or sperm production. But a single FSH number on a lab report can be surprisingly tricky to interpret, because the hormone fluctuates with age, sex, time of the menstrual cycle, and even what supplements you are taking.

What FSH Actually Does

FSH is one half of a hormonal partnership. The hypothalamus, a small region at the base of the brain, releases gonadotropin-releasing hormone (GnRH) in pulses. Those pulses tell the pituitary gland to secrete two gonadotropins: FSH and luteinizing hormone (LH). Together, these two hormones travel through the bloodstream to the ovaries or testes and drive the processes that produce eggs and sperm.¹

In women, FSH stimulates the growth and maturation of ovarian follicles, the small fluid-filled sacs that each contain an egg. It binds to receptors on the granulosa cells surrounding those follicles and triggers a cascade of signals that promote follicle development and the production of estrogen.² Early in each menstrual cycle, rising FSH coaxes a group of follicles to start growing. Eventually one follicle becomes dominant, and the others regress. That dominant follicle produces increasing amounts of estrogen, which feeds back to the pituitary and brings FSH levels down, a built-in brake that prevents too many eggs from maturing at once.

In men, FSH acts on Sertoli cells inside the testes. Sertoli cells are sometimes called “nurse cells” because they support and nourish developing sperm. FSH promotes their proliferation and helps them produce the survival factors and nutrients that germ cells need to mature into functional sperm.³ Interestingly, animal studies show that losing FSH entirely does not shut down sperm production altogether. Mice engineered to lack either the FSH gene or its receptor still produce some sperm, though at reduced numbers. FSH appears to be required for maintaining a full complement of Sertoli cells and keeping germ cell numbers high, but it is not strictly essential for completing the sperm-production process itself.⁴

Why Your Doctor Orders the Test

An FSH blood test is ordered for a range of reasons, and the clinical context changes everything about how the number is read. In women, the most common reasons include investigating irregular or absent periods, evaluating difficulty conceiving, and assessing whether menopause has begun. In men, it is typically part of a fertility workup when a semen analysis shows low or absent sperm. In children, it can help evaluate early or delayed puberty.

Because FSH is part of a feedback loop, a single value tells you something about the whole chain. If the ovaries or testes are struggling, they produce less of the hormones that normally tell the pituitary to ease off, and FSH rises in response. If the pituitary itself is underperforming, or the brain’s signaling to the pituitary is disrupted, FSH stays low even when the gonads need stimulation. The direction of the abnormality, high or low, points the investigation toward different parts of the system.

What Normal Levels Look Like

Reference ranges for FSH vary somewhat between laboratories, but there are general patterns. In premenopausal women, FSH during the early follicular phase (roughly days two through four of the menstrual cycle) typically falls between about 3 and 10 IU/L. A mid-cycle surge pushes it higher briefly, and then it drops again in the luteal phase. In postmenopausal women, levels commonly rise above 25 to 30 IU/L and can climb much higher. In adult men, FSH is relatively stable day to day, with reference ranges generally in the range of about 1.5 to 12 IU/L.

These numbers come with a significant asterisk. FSH concentrations can vary due to the assay your lab uses, the time of day the blood was drawn, where you are in your menstrual cycle, and even random hour-to-hour fluctuations.⁵ A single measurement is a snapshot, and clinicians often repeat it or combine it with other hormone tests before drawing firm conclusions.

High FSH in Women and What It Signals

Elevated FSH in a premenopausal woman usually points to the ovaries running low on follicles. As the pool of available follicles shrinks, the ovaries produce less inhibin B, a protein that normally acts as a brake on FSH secretion. With less inhibin B in circulation, the pituitary cranks up FSH in an attempt to coax the remaining follicles into action.⁶ This is the body’s compensatory mechanism: the brain senses that the ovaries are quieter than expected, so it yells louder.

During perimenopause, this process plays out gradually. FSH starts rising years before the final menstrual period, and levels can bounce around considerably from cycle to cycle. The rise in FSH is thought to help maintain normal estrogen levels in the follicular phase for as long as possible, even as the ovarian reserve dwindles.⁷ Once menopause is established, meaning twelve consecutive months without a period, FSH typically stays persistently elevated.

In younger women, a high FSH on day two or three of the cycle is a red flag for diminished ovarian reserve. It doesn’t necessarily mean pregnancy is impossible, but it does suggest fewer eggs are available and the remaining follicles may respond less robustly to stimulation during fertility treatment. Premature ovarian insufficiency, where the ovaries stop functioning normally before age 40, also presents with elevated FSH.

High FSH in Men

In men, elevated FSH generally indicates that the testes are not producing sperm normally and the pituitary is compensating by producing more FSH. An elevated level is considered indicative of abnormal sperm production and may point to primary testicular failure, meaning the problem originates in the testes themselves rather than the brain or pituitary.⁸

In men with no sperm in the ejaculate (azoospermia), FSH values can help predict the severity of the underlying problem. Research has found that men with more severe testicular tissue damage tend to have significantly higher FSH levels. In one study of men with non-obstructive azoospermia, those with unfavorable tissue patterns had a mean FSH around 23 IU/L compared to roughly 13 IU/L in those with more favorable patterns.⁹ Higher FSH in this context is a clue that more testicular tissue has been affected, though it is not a perfect predictor for any individual.

One increasingly common scenario involves men who have used anabolic steroids or exogenous testosterone. These substances suppress the body’s own production of FSH and LH because the brain detects high circulating testosterone and shuts down its signals to the pituitary. Sperm production can drop to zero during use.¹⁰ When a man with suppressed FSH and LH presents with infertility, the blood test makes the cause fairly obvious. Recovery of sperm production after stopping exogenous testosterone varies considerably from person to person.

Low FSH and What It Means

Low FSH usually points to a problem higher up in the signaling chain, at the level of the hypothalamus or pituitary. In women, one of the more common causes is functional hypothalamic amenorrhea, a condition where the GnRH pulses from the hypothalamus slow down or stop. This in turn means the pituitary doesn’t get adequate stimulation to release FSH and LH, and ovulation ceases.¹¹ The condition is often triggered by excessive exercise, significant weight loss, chronic stress, or some combination of these. The good news is that it is reversible: addressing the underlying stressor often restores normal hormone pulsing and menstrual cycles.¹²

In both men and women, pituitary tumors, head injuries affecting the pituitary, or certain medications can also suppress FSH. Hormonal contraceptives work partly by suppressing gonadotropin release, so finding low FSH in someone on the pill is expected, not alarming. The clinical picture matters as much as the number.

FSH Versus AMH for Ovarian Reserve

If you are going through a fertility evaluation, you will likely hear about another hormone test alongside FSH: anti-Müllerian hormone, or AMH. Both are used to estimate ovarian reserve, but they have different strengths, and clinicians increasingly lean on AMH in certain situations.

The main limitation of FSH as an ovarian reserve marker is that it fluctuates through the menstrual cycle, so timing matters. It also doesn’t perform well at distinguishing between normal and high follicle counts. In studies comparing the two markers, AMH has proven better at clustering women by the size of their remaining follicle pool, particularly at telling apart women with normal reserve from those with above-average reserve.¹³ FSH, on the other hand, is more useful at flagging very low reserve. It tends to become clearly abnormal only once the follicle pool has dropped substantially.

Age complicates the picture further. Research comparing both markers across age groups found that in women under 35, early-cycle FSH was more closely tied to the number of follicles available and the number of eggs retrieved during IVF. In women 35 and older, AMH was the better predictor of those outcomes.¹⁴ Most fertility clinics now measure both, along with an ultrasound count of small antral follicles, to get the fullest picture.

AMH has another practical advantage: it can be drawn on any day of the cycle without significantly affecting the result. FSH requires timing the blood draw to the early follicular phase for the number to be meaningful. If your period is irregular or absent, timing an FSH draw properly can be difficult, making AMH the more convenient test in those situations.¹⁵

Things That Can Throw Off Your Results

Several factors can produce misleading FSH numbers. One that gets surprisingly little attention is biotin, also known as vitamin B7 or vitamin H. Biotin supplements have become popular for hair, skin, and nail health, and many multivitamins contain it. The problem is that biotin can interfere with the immunoassay technology used to measure FSH and many other hormones. In FSH testing specifically, high biotin levels have been shown to produce falsely low readings.¹⁶ If you are taking a biotin supplement, even at modest doses, mention it to your doctor before hormone testing. Most labs recommend stopping biotin at least 48 to 72 hours before a blood draw.

Lab-to-lab variability is another issue. Different assay platforms can produce different absolute numbers for the same blood sample. One older quality-assessment study found that only about 15% of participating laboratories achieved performance with less than 10% bias, while a similar proportion produced results that could be clinically misleading. The remaining majority fell somewhere in between.¹⁷ Assay standardization has improved since then, but the takeaway remains relevant: comparing FSH values obtained from different labs or different time points is less reliable than tracking results from the same laboratory over time.

Timing within the menstrual cycle, as mentioned earlier, is critical for premenopausal women. An FSH drawn mid-cycle during the ovulatory surge would look abnormally high and could be mistaken for diminished ovarian reserve. This is why clinicians specify a day-two or day-three blood draw when using FSH to assess fertility.

FSH in Fertility Treatment

Beyond diagnosis, FSH plays a direct therapeutic role. Injectable FSH is one of the core medications used in IVF and other assisted reproductive technologies. The logic is straightforward: by administering FSH from outside the body, clinicians override the natural selection process that would normally let only one follicle mature. Higher FSH levels stimulate multiple follicles to grow simultaneously, producing several eggs for retrieval.

The FSH used in these protocols comes in two main forms: recombinant FSH, manufactured using genetic engineering in cell cultures, and urinary-derived FSH, purified from the urine of postmenopausal women (whose natural FSH levels are high). Both are effective, but they are not identical. In a large randomized trial comparing recombinant FSH with highly purified urinary FSH in women undergoing IVF, the recombinant form required a shorter treatment duration, fewer total doses, and produced more follicles and more retrieved eggs.¹⁸ The choice between formulations often depends on cost, availability, and individual clinical factors.

A woman’s baseline FSH level before starting treatment helps predict how she will respond to stimulation. Higher baseline FSH suggests fewer remaining follicles and typically means the ovaries will respond less vigorously, sometimes requiring higher medication doses. Very high baseline FSH can prompt a conversation about whether IVF is likely to succeed or whether donor eggs should be considered.

Beyond Reproduction

For decades, FSH was thought of as a purely reproductive hormone. Emerging research is challenging that assumption. Animal studies and observational data in humans have generated interest in the idea that rising FSH levels, particularly during the menopausal transition, contribute to bone loss and increased body fat independent of declining estrogen.¹⁹ The conventional explanation for postmenopausal osteoporosis has always been estrogen withdrawal. But some researchers have proposed that high FSH itself may directly promote bone breakdown and fat accumulation.²⁰

This is still very much an open question. Mouse studies support the idea, and some human observational data align with it, but interventional studies in humans have not definitively settled whether blocking FSH would protect bones or reduce fat mass. Researchers have pointed out that disentangling the effects of FSH from those of estrogen in human menopause is difficult, because both change simultaneously. If future work confirms an independent role for FSH in bone and metabolic health, it could open the door to new treatments, including antibodies that block FSH, aimed at preventing osteoporosis or obesity. For now, these findings are provocative rather than actionable for patients.

How FSH Binds to Its Receptor

One reason FSH is so specific in its effects is the way it physically connects with its receptor. FSH is a glycoprotein, meaning it is a protein decorated with sugar chains. It locks onto a receptor called FSHR, found on the surface of granulosa cells in the ovaries and Sertoli cells in the testes. Structural studies have revealed that this binding happens in two steps. First, FSH docks onto a high-affinity binding region on the receptor’s outer domain. That initial docking reshapes part of the FSH molecule, opening up a second binding pocket. The receptor then inserts a chemically modified part of itself, a sulfated tyrosine residue, into that newly formed pocket, and this second contact triggers the receptor to activate and send signals inside the cell.²¹ This two-step mechanism helps explain why FSH activates only its own receptor and not the closely related receptors for LH or thyroid-stimulating hormone, despite all three hormones sharing a common structural subunit. The specificity is built into the shape of the handshake between hormone and receptor.